MicroRNA-29 specifies age-related differences in the CD8+ T cell immune response
- PMID: 34758312
- DOI: 10.1016/j.celrep.2021.109969
MicroRNA-29 specifies age-related differences in the CD8+ T cell immune response
Abstract
MicroRNAs (miRNAs) have emerged as critical regulators of cell fate in the CD8+ T cell response to infection. Although there are several examples of miRNAs acting on effector CD8+ T cells after infection, it is unclear whether differential expression of one or more miRNAs in the naive state is consequential in altering their long-term trajectory. To answer this question, we examine the role of miR-29 in neonatal and adult CD8+ T cells, which express different amounts of miR-29 only prior to infection and adopt profoundly different fates after immune challenge. We find that manipulation of miR-29 expression in the naive state is sufficient for age-adjusting the phenotype and function of CD8+ T cells, including their regulatory landscapes and long-term differentiation trajectories after infection. Thus, miR-29 acts as a developmental switch by controlling the balance between a rapid effector response in neonates and the generation of long-lived memory in adults.
Keywords: CD8+ T cell; activation threshold; adaptive immunity; extracellular vesicle; gene regulation; immunological memory; miR-29; microRNA; naive; neonate.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests Authors Minh T. N. Le, Andrew Grimson, Brian D. Rudd, Kristel Yee Mon and Luyen Tien Vu, are co-inventors of a patent application entitled ‘Delivery of nucleic acids into T cells’ (US 63/000,468). Minh T.N. Le is a cofounder and advisor of Carmine Therapeutics, a company that develops EV-based therapeutics.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
